Skip to content

Protecting the Future of Pregnancy Care

Nuvo’s category-defining platform is protected by a robust intellectual property portfolio designed to safeguard innovation end-to-end—from how data is captured and processed to how clinically meaningful insights are delivered. We don't just protect a device; we protect the entire pipeline that transforms raw signals into life-changing insights.

Hero_IP
60
Issued Utility Patents (16 U.S. / 44 Global)
23
Pending Utility Applications
10
Issued Design Patents

Protecting the Entire Data & Insight Pipeline

Instead of relying on narrow technical claims, Nuvo’s IP strategy creates durable barriers to entry by protecting how data is captured, processed, and transformed into clinical value.

The Foundation
Data Acquisition & Sensors

Protecting the hardware designs, sensor placements, and wearable configurations that enable consistent, high-quality signal capture across different body types and gestational ages.

Signal Separation & Quality

Solving the Hard Problems

Proprietary methods for separating fetal heart signals from maternal noise and motion artifacts, ensuring clinical-grade data integrity in real-world environments.

AI & Clinical Interpretation

From Signals to Insights

Protecting the advanced algorithms and AI models that transform raw ECG and PCG data into actionable clinical assessments for fetal and maternal well-being

More Than the Sum of Its Parts

More Than the Sum of Its Parts

Nuvo is a pioneer in jointly analyzing multiple biophysical signals at scale. Our patents protect the fusion of electrical (ECG) and acoustic (PCG) data, allowing the system to compensate for motion and provide a coherent, validated view of pregnancy that single-signal technologies cannot replicate.

 

Fetus multi-signals

A Self-Reinforcing Advantage

Because our platform enables continuous monitoring in real-world settings, it generates a growing repository of high-quality, longitudinal data. This data strengthens our AI models, which in turn improves clinical performance and reinforces adoption—a flywheel effect protected by our core IP.

 

Strategic Value Beyond the Product

Strategic Value Beyond the Product

Our IP strategy isn't just about protecting features; it’s about creating long-term strategic value. This supports competitive defense, partnership leverage for global collaborations, and clear ownership over an entirely new category of maternal health data.

 

Competitive Defense

Prevents replication of our end-to-end system

Partnership Leverage

Enables global licensing and strategic collaborations

Regulatory Confidence

Demonstrates full control over our core technologies

Long-term Optionality

Supports expansion into new clinical indications and insights